FDA Addresses Suicide Risk in Anti-Baldness Drug

Published on June 10, 2022

The FDA has decided to keep popular anti-baldness pill Propecia on the market, but with a new warning about the potential for suicidal behavior. This is like telling someone they can still take a ride on their favorite roller coaster, but now they have to be aware that there might be a sudden drop in the middle of the ride! The FDA recognizes the importance of informing patients about this serious side effect and taking steps to protect their well-being. It’s crucial that individuals who are considering or currently taking Propecia are aware of these risks and monitor their mental health closely. While the decision may disappoint some people, it’s important to prioritize safety above all else and make informed choices. If you’re interested in learning more about this topic, I encourage you to explore the underlying research and consult with a healthcare professional for personalized guidance.

U.S. health regulators rejected a request to remove popular anti-baldness pill Propecia and its generic versions from the market, but for the first time required patient notification about reports of suicidal behavior in men taking the drug. The U.S. Food and Drug…

Read Full Article (External Site)

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes:

<a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>